Economics of Preventing, Screening, and Treating Oral Cancers
Oral cancers are the commonest among all head and neck squamous cell cancers (HNSCC). Cancers of the oral cavity in the developing world differ from those in the Western world in terms of age, subsites of disease, etiology, and molecular biology. Poverty, illiteracy, advanced stage at presentation, lack of access to healthcare, and poor treatment infrastructure are also major challenges. The annual GDP (gross domestic product) spent on healthcare is very low in the low-resource countries compared to high-income countries .
- 3.Edejer TT, Baltussen R, Adam T, Hutubessey R, Acharya A, Evand DB, CJL M. WHO guide to cost-effectiveness analysis. Geneva: WHO; 2003.Google Scholar
- 4.Robberstad B. QALYs vs DALYs vs LYs gained: what are the differences, and what difference do they make for health care priority setting? Norwegian J Epidemiol. 2005;15(2):183–91.Google Scholar
- 8.Laxminarayan R, Chow J, Shahid-Salles SA. In: Jamison DT, Breman JG, Measham AR, et al., editors. Intervention cost-effectiveness: overview of main messages in disease control priorities in developing countries. 2nd ed. Washington, DC: World Bank; 2006.Google Scholar
- 9.Ranson K, Jha P, Chaloupka FJ, Nguyen S. The effectiveness and cost-effectiveness of price increases and other tobacco-control policies. In: Jha P, Chaloupka F, editors. Tobacco control in developing countries. Oxford, UK: Oxford University Press; 2000.Google Scholar
- 11.Dedhia RC, Smith KJ, Johnson JT, Roberts M. The cost-effectiveness of community-based screening for oral cancer in high-risk males in the United States: a Markov decision analysis approach. Laryngoscope. 2011;121(5):952–60. doi: 10.1002/lary.21412. Epub 2011 Mar 7.CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, NR MM, Hughes M. Head and neck cancers, version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2014;12(10):1454–87.CrossRefGoogle Scholar
- 16.Diagnosis and management of head and neck cancer, Guideline No. 90 ISBN 9781905813001 November 2006. www.sign.ac.uk/guidelines/.
- 17.Guidance. nice.org.uk/CSGHN.
- 19.American Society of Clinical Oncology, Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, Ang KK, Clayman GL, Fisher SG, Forastiere AA, Harrison LB, Lefebvre JL, Leupold N, List MA, O'Malley BO, Patel S, Posner MR, Schwartz MA, Wolf GT. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol. 2006 Aug 1;24(22):3693–704.CrossRefGoogle Scholar
- 20.Improving outcomes in head and neck cancers: Evidence Update May 2012 available from www.evidence.nhs.uk/topic/head-and-neck-cancers.
- 21.Indian council of medical research (ICMR): Guidelines for Management of Buccal Mucosa Cancer, 2010.Google Scholar
- 22.Anderson BO, Yip CH, Smith RA, Shyyan R, Sener SF, Eniu A, Carlson RW, Azavedo E, Harford J. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer. 2008;113(8 Suppl):2221–43.CrossRefPubMedGoogle Scholar
- 24.Wee JT, Anderson BO, Corry J, D'Cruz A, Soo KC, Qian CN, Chua DT, Hicks RJ, Goh CH, Khoo JB, Ong SC, Forastiere AA, Chan AT, Asian Oncology Summit. Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 2009;10(11):1086–92.CrossRefPubMedGoogle Scholar